We are happy to announce that Manyata has crossed 1000+ facility registrations across 6 states - Uttar Pradesh, Jharkhand, Maharashtra, Karnataka, Rajasthan and Tamil Nadu. We could not have reached this far without your unrelenting commitment towards the program.
We would also like to thank our partners for their continued support in ensuring that we stay the course to achieve our goal of making India a safer country for women to give birth. 

In this newsletter, we are sharing events where our team represented Manyata, key trainings organised this month and some new research in the sector.
Hope you enjoy reading it!
Orientation sessions on LaQshya-Manyata
  • An orientation session on LaQshya-Manyata was held at Kolhapur OBGYN society on 26 February, with 20 doctors in attendance.
  • Karad OBGYN society independently organized an orientation session on 26 February.  Dr. Milind Shah, a Manyata lead assessor, hosted the session with 29 doctors in attendance, many of whom expressed interest in joining the program.
Staff training for LaQshya-Manyata was organized at a Government training hall in Nanded on 25 & 26 February. Close to 22 nurses and staff members received training, on 26 Clinical and Facility Standards, from the Civil Surgeon and the Resident Medical Officer.             
Manyata Partners’ Meeting with FOGSI President
Dr. Alpesh Gandhi hosted a meeting, for Manyata partners and leadership, on 22 February at FOGSI headquarters. The meeting focused on discussing each partner’s role in amplifying the program’s impact in the coming year.
Manyata at AMOGS Conference, 25 February 2020
LaQshya-Manyata was extensively showcased in the 3-day AMOGS conference at Amravati. A LaQshya-Manyata stall was set up at the venue where providers were apprised about the program. Dr. Hrishikesh Pai also made a presentation on LaQshya-Manyata at the conference. The team received a lot of interest from participants about the program and was invited by the Presidents & Secretaries of local OBGYN societies to showcase Manyata in their upcoming CMEs.

The Tribune l Novel coronavirus cannot pass from mother to child late in pregnancy: Lancet
: The 2019 novel coronavirus disease (COVID-19) may not pass to the child in the womb during late pregnancy, or cause severe health outcomes in a newborn, according to a study published in The Lancet journal. They also found that symptoms from COVID-19 infection in pregnant women were similar to those reported in non-pregnant adults, and no women in the study developed severe pneumonia or died.

Read more
The New Indian Express l Depression linked to low baby weight
Summary: A new study from public health facilities in India reveals that, women with depression during pregnancy are twice as likely of delivering low-birth-weight babies as compared to women with no depressive symptoms.
Read More
NY Times l A Daily Aspirin for Pregnancy?
Summary: According to a randomized, double-blinded placebo-controlled study of 11,976 women, in six countries, pregnant women who take a daily baby aspirin may reduce the risk for premature birth. The study was published in Lancet.
Read More
Follow these handles to stay clued into the most recent developments in the health space. 

Dr. Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO)
Twitter: @DrTedros 
Facebook: @DrTedros.Official


Happy to help.

Please reach out to us at for queries/information.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
NonProfit · Weber Shandwick, 15th Floor, Tower B, DLF Cyber Greens · DLF Phase 2, Sector 24, Gurugram · Gurugram 122002 · India

Email Marketing Powered by Mailchimp